FIELD: biotechnology.
SUBSTANCE: following is provided: methods of treating or preventing an autoimmune disease, comprising administering the CD40L-specific Tn3 scaffold protein at a dose of 500 mg to 3,000 mg to a subject in need thereof.
EFFECT: inventions are used for the treatment or prevention of such diseases as focal segmental glomerulosclerosis, systemic sclerosis, myositis, antiphospholipid syndrome, autoimmune hepatitis, lupus nephritis, idiopathic thrombocytopenic purpura, Sjogren's syndrome, IgG-related disease, erythematous lupus.
14 cl, 26 dwg, 2 tbl, 15 ex
| Title | Year | Author | Number |
|---|---|---|---|
| ANTIBODIES TO CD40 FOR USE IN THE TREATMENT OF SJOGREN'S SYNDROME | 2018 |
|
RU2790558C2 |
| TREATING AUTOIMMUNE DISEASES WITH CD154 ANTIBODIES | 2015 |
|
RU2695443C2 |
| APPLICATION OF SINGLE DOSE OF CD20-SPECIFIC BINDING MOLECULES | 2006 |
|
RU2421242C2 |
| METHOD FOR DETERMINING ANTI-DRUG ANTIBODY ISOTYPE | 2011 |
|
RU2574976C2 |
| HUMAN ANTI-CD40 ANTAGONIST MONOCLONAL ANTIBODY | 2007 |
|
RU2491295C2 |
| METHODS AND COMPOSITIONS FOR REDUCING IMMUNOGENICITY USING NON-DEPLETION B-CELL INHIBITORS | 2020 |
|
RU2821892C2 |
| APPLICATION OF ANTI-CD40-ANTIBODIES | 2006 |
|
RU2442606C2 |
| CD40L-SPECIFIC CARCASS STRUCTURES DERIVED FROM Tn3, AND METHODS FOR USE THEREOF | 2012 |
|
RU2704992C2 |
| METHOD OF TREATING JOINT INJURIES | 2006 |
|
RU2457860C2 |
| ANTIBODIES TO CD38 AND PHARMACEUTICAL COMPOSITIONS BASED THEREON FOR TREATMENT OF AUTOIMMUNE DISEASE MEDIATED BY AUTOANTIBODIES | 2020 |
|
RU2809565C2 |
